Vivos Therapeutics Inc. (VVOS) Social Stream



Vivos Therapeutics Inc. (VVOS): $2.29

0.03 (+1.33%)

POWR Rating

Component Grades

Momentum

F

Stability

D

Sentiment

Quality

C

VIVOS THERAPEUTICS INC (VVOS) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering VVOS.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-08-13 2 $12 $10 $11 $12.44 -11.58%
2021-11-16 2 $12 $9.75 $10.875 $12.44 -12.58%
2022-04-05 1 $8 $8 $8 $12.44 -35.69%
2022-05-20 1 $4 $4 $4 $12.44 -67.85%
2022-12-21 1 $2 $2 $2 $12.44 -83.92%
2023-06-09 1 $1 $1 $1 $12.44 -91.96%
2023-08-17 1 $0.7 $0.7 $0.7 $12.44 -94.37%

Price Target Last Issued April 5, 2022

The Trend in the Analyst Price Target


VVOS's average price target has moved up $6.5 over the prior 24 months.

Over the past 136 days, VVOS's average upside potential has been 1,459.11%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2023-04-03 1 1.0 1.0 1.0 0.340 194.12%
2023-06-09 1 1.0 1.0 1.0 0.422 136.97%
2023-08-17 1 0.7 0.7 0.7 0.319 119.44%
2023-08-17 1 17.5 17.5 17.5 0.319 5385.89%

VVOS Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1 1 0 0 0 0 1

The Trend in the Broker Recommendations


Over the past 21 months, VVOS's average broker recommendation rating improved by 0.

The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.

  • To contextualize these metrics, consider that out of all US stocks, VIVOS THERAPEUTICS INC's number of analysts covering the stock is greater than 5.66% of them.
  • VIVOS THERAPEUTICS INC's variance in analysts' estimates is lower than 68.8% of all US stocks.
  • In terms of how VIVOS THERAPEUTICS INC fares relative to stocks in the micro market cap category, note that its upside potential (average analyst target price relative to current price) is higher than 50.54% of that group.
  • VIVOS THERAPEUTICS INC's average analyst price target is greater than 79.56% of Medical Equipment stocks.

In the Medical Equipment industry, FEMY, IONM, and LUCD are the three stocks most similar to VIVOS THERAPEUTICS INC regarding the price target and analyst recommendation information presented here.

Is VVOS a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!